Pfizer plays hardball in weight-loss drug fight
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing for wider global dollar adoption.…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like FT News Briefing →
Weight boss? Competition for Novo Nordisk
Big deals in Big Pharma
AI Labs: Sam Altman may make or break OpenAI
The Weight Loss Drug Revolution: Transforming Bodies and Reshaping Economies | The Global Brief
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.